NIH Weekly Funding Opportunities and Policy Notices
Funding Opportunity PAR-23-299 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to support developmental/exploratory studies in preparation for health promotion, disease prevention, treatment, or treatment services research to improve health in Native American (NA) populations. Applications may include 1) etiologic research, where there is a significant gap in knowledge, that will directly inform intervention development or adaptations, 2) research to develop and pilot test new or adapted interventions for feasibility, acceptability, and scalability, 3) research to test the short-term efficacy of interventions, 4) where a sufficient body of knowledge on intervention efficacy exists, research on strategies to overcome barriers to the adoption, integration, scale-up, and sustainability of effective interventions. Existing data suggest that significant acute and chronic disease inequities exist for NA populations. Concurrently, NA populations experience unique sociopolitical, historical, and environmental stressors and risks that may exacerbate health conditions and/or impact the effectiveness of existing solutions to address the conditions. They also possess unique strengths and resiliencies that can mitigate stressors or inform intervention strategies. Through this announcement, culturally informed exploratory/developmental research is sought that builds upon community knowledge, resources, and resilience to provide foundational knowledge for future science-based, culturally appropriate solutions to reduce morbidity and mortality through identification and remediation of precursors to diseases and disorders and through culturally informed treatment. For the purposes of this FOA, Native Americans include the following populations: Alaska Natives, American Indians (whose ancestral lands fall at least partially within the U.S. mainland border), and Native Hawaiians. The term Native Hawaiian means any individual any of whose ancestors were natives, prior to 1778, of the area which
Notice NOT-TW-23-007 from the NIH Guide for Grants and Contracts
Notice NOT-DE-23-016 from the NIH Guide for Grants and Contracts
Notice NOT-HG-23-050 from the NIH Guide for Grants and Contracts
Notice NOT-DE-23-013 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-MH-24-322 from the NIH Guide for Grants and Contracts. The goal of this initiative is to support research designed to develop models of pre-teen suicide that a.) explain risk states that transition to risk behaviors, including self-harm and suicide attempts; b.) identify protective factors that could be developed/enhanced to change the risk trajectory, both proximal and distal; and c.) identify intervention targets and timing, as well as scalable assessment approaches that have clinical utility for characterizing both risk/protective factors and suicide risk status and outcomes.
Funding Opportunity RFA-MH-24-320 from the NIH Guide for Grants and Contracts. The goal of this initiative is to support research designed to develop models of pre-teen suicide that a.) explain risk states that transition to risk behaviors, including self-harm and suicide attempts; b.) identify protective factors that could be developed/enhanced to change the risk trajectory, both proximal and distal; and c.) identify intervention targets and timing, as well as scalable assessment approaches that have clinical utility for characterizing both risk/protective factors and suicide risk status and outcomes.
Funding Opportunity RFA-DK-23-516 from the NIH Guide for Grants and Contracts. This is a non-competitive notice of funding opportunity (NOFO) intended to fund a single award. The National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK) is announcing its intent to issue a single source cooperative agreement to Johns Hopkins University to continue the support of the Data Coordinating Center of the NASH Clinical Research Network (NASH CRN) as they complete and report their active clinical treatment trial, and close out, analyze, and report the networks prospective database (DB3).The NASH CRN has been sponsored by the NIDDK since 2002, and was renewed in 2009, 2014 and 2019. Research in the NASH CRN has been focused on the etiology, contributing factors, natural history, complications, and therapy of nonalcoholic steatohepatitis.
Funding Opportunity RFA-DK-23-018 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to continue the support the Childhood Liver Disease Research Network (ChiLDReN) to conduct clinical and translational research on rare pediatric liver diseases. ChiLDReN will be composed of a Scientific and Data Coordination Center (DCC), Clinical Centers (CC) , and the NIDDK/NIH as the sponsor of the Network. ChiLDReN will continue clinical and translational research on pediatric liver diseases that include: Biliary Atresia; Alagille syndrome; alpha-1-antitrypsin deficiency; Progressive Familial Intrahepatic Cholestasis syndromes; Bile acid synthesis defects; Mitochondrial hepatopathies; Idiopathic Neonatal Hepatitis; Cystic Fibrosis Liver Disease; and primary sclerosing cholangitis.
Notice NOT-OD-23-176 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-171 from the NIH Guide for Grants and Contracts
Funding Opportunity RFA-DK-23-017 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to continue the support the Childhood Liver Disease Research Network (ChiLDReN) to conduct clinical and translational research on rare pediatric liver diseases. ChiLDReN is composed of a Scientific and Data Coordination Center (SDCC) and Clinical Centers (CC). ChiLDReN will continue clinical and translational research on pediatric liver diseases that include: Biliary Atresia; Alagille syndrome; alpha-1-antitrypsin deficiency; Progressive Familial Intrahepatic Cholestasis syndromes; Bile acid synthesis defects; Mitochondrial hepatopathies; Idiopathic Neonatal Hepatitis; Cystic Fibrosis Liver Disease; and primary sclerosing cholangitis.
Notice NOT-OD-23-177 from the NIH Guide for Grants and Contracts
Notice NOT-HS-23-021 from the NIH Guide for Grants and Contracts
Notice NOT-HS-23-020 from the NIH Guide for Grants and Contracts
Funding Opportunity PA-23-262 from the NIH Guide for Grants and Contracts. The purpose of the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32) is to support research training of highly promising postdoctoral candidates who have the potential to become productive, independent investigators in scientific health-related research fields relevant to the missions of the participating NIH Institutes and Centers. Applications are expected to incorporate exceptional mentorship. This Notice of Funding Opportunity (NOFO) is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Funding Opportunity PA-23-261 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) will support students at institutions without NIH-funded institutional predoctoral dual-degree training programs. The purpose of the Kirschstein-NRSA, dual-doctoral degree, predoctoral fellowship (F30) is to enhance the integrated research and clinical training of promising predoctoral students, who are matriculated in a combined MD/PhD or other dual-doctoral degree training program (e.g. DO/PhD, DDS/PhD, AuD/PhD, DVM/PhD), and who intend careers as physician/clinician-scientists. Candidates must propose an integrated research and clinical training plan and a dissertation research project in scientific health-related fields relevant to the missions of the participating NIH Institutes and Centers. The fellowship experience is expected to clearly enhance the individual's potential to develop into a productive, independent physician/clinician-scientist. This NOFO is designed specifically for candidates proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial, but does allow candidates to propose research experience in a clinical trial led by a sponsor or co-sponsor.
Notice NOT-AR-23-023 from the NIH Guide for Grants and Contracts
Notice NOT-NS-23-110 from the NIH Guide for Grants and Contracts
Notice NOT-OD-23-174 from the NIH Guide for Grants and Contracts